Tazemetostat Hydrobromide
CAS 1557520-12-0Small Molecule
Overview
Tazemetostat Hydrobromide is a small molecule inhibitor of the EZH2 methyltransferase, which is involved in the regulation of gene expression through histone modification. It is primarily used in the treatment of certain types of cancers, including epithelioid sarcoma.
Therapeutic areas
Oncology
Verified Supplier Partner
Do you supply Tazemetostat Hydrobromide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.